FDA approves pembrolizumab for BCG-unresponsive, high-risk non-muscle invasive bladder cancer
Case Medical Research
Topics & Concepts
PembrolizumabBladder cancerMedicineOncologyCancerInternal medicineImmunotherapyBladder and Urothelial Cancer TreatmentsAmino Acid Enzymes and MetabolismCancer Immunotherapy and Biomarkers